Literature DB >> 12148900

Acute lymphoblastic leukemia in adult first manifested as severe aplastic anemia--role of molecular analysis in correct diagnosis.

Tadeusz Robak1, Jacek Bartkowiak, Halina Urbańska-Rys, Anna Szmigielska-Kapłon, Bogusława Strzelecka, Krzysztof Chojnowski.   

Abstract

Aplastic anemia (AA) may sometimes precede the diagnosis of acute lymphoblastic leukemia (ALL) in children. Such presentation of ALL is externally rare in adults and until now only few such cases have been reported. We present a 40-year-old male with ALL common type, which developed 14 months after the diagnosis of severe AA, successfully treated with corticosteroids. ALL was treated with standard induction chemotherapy but remission has not been achieved. The patient died 6 weeks after the diagnosis of ALL because of central nervous system bleeding. The pattern of IgH gene rearrangement analyzed with PCR method in bone marrow from the period of AA diagnosis and in peripheral blood mononuclear cells from ALL diagnosis showed two different monoclonal IgH configurations as the results of biallelic monoclonal rearrangement of IgH genes. The observed bands in both specimens were identical and indicated that leukemic cells originated from B-cell progenitor were also present in the bone marrow when AA was diagnosed. We suggest that molecular analysis of monoclonality in patients with AA may be important for proper selection of the rare cases of ALL first presenting as marrow aplasia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12148900     DOI: 10.1080/10428190290021605

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  2 in total

1.  Acute lymphoblastic leukemia of childhood presenting as aplastic anemia: report of two cases.

Authors:  Laura Villarreal-Martínez; José Carlos Jaime-Pérez; Marisol Rodríguez-Martínez; Oscar González-Llano; David Gómez-Almaguer
Journal:  Rev Bras Hematol Hemoter       Date:  2012

2.  Spontaneous remission of acute lymphoblastic leukemia: A case report.

Authors:  Timm Höres; Knut Wendelin; Kerstin Schaefer-Eckart
Journal:  Oncol Lett       Date:  2017-10-30       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.